June 4, 2025 Delta-8 Inhalable Product Takeaway - Dangerous products will be cited even if they do not contain disease claims
May 28, 2025 Avoid Comparing Products to Drugs (most of the time) Takeaway - Use FDA’s helpful resource (criterion 6)
May 21, 2025 Unallowable Ingredient Results in Warning Letter Takeaway - Here are tips on using FDA’s ingredient directory
May 14, 2025 3 Animal Product Companies Receive Warning Letters Takeaway - Extra attention is paid to animal CBD products
May 7, 2025 Celebrating 200 Weekly WLW Posts! Takeaway - Learning from others' mistakes helps you be compliant
April 30, 2025 Best Practices When Making Competitor Comparison Claims Takeaway - Ensure statements are not disparaging
April 23, 2025 Navigating the Risks of Therapy-Adjacent Health Claims Takeaway - Use FDA's helpful resource (Criterion 7)
April 16, 2025 OTC Topical “Inactive” Ingredient Marketing Claims Takeaway - OTC Topical “Inactive” Ingredient Marketing Claims “Extra” claims are often non-compliant
April 9, 2025 Best Practices When Making Biomarker and Implied Claims Takeaway - Use FDA’s helpful resource (Criterion 2)
March 26, 2025 Influencers Must Disclose Free Product Takeaway - Brands should monitor influencer posts for compliance